CYMER INC Spending and interest coverage
- R&D / revenue · 12 months: Value 39.15%; Formula and calculation Research and development expense / revenue. Period ending 2013-03-31..
- Stock-based compensation / revenue · 12 months: Value 5.76%; Formula and calculation Share-based compensation / revenue. Period ending 2013-03-31..
- Interest coverage · 12 months: Value -125.27×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2013-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 39.15% | Research and development expense / revenue. Period ending 2013-03-31. $190.92M ÷ $487.68M × 100 ≈ 39.15% |
| Stock-based compensation / revenue · 12 months | 5.76% | Share-based compensation / revenue. Period ending 2013-03-31. $28.09M ÷ $487.68M × 100 ≈ 5.76% |
| Interest coverage · 12 months | -125.27× | Operating income ÷ reported interest expense. $-71.40M ÷ $570.00K ≈ -125.27× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 190.92M USD | Research and Development Expense |
| Revenue | 487.68M USD | |
| Stock-based compensation | 28.09M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -71.40M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 570.00K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2013-03-31 | $190.92M | $487.68M | $28.09M | $-71.40M | $570.00K | 39.15% | 5.76% | -125.27× | Reported |
| 2012-12-31 | $187.69M | $538.63M | $26.75M | $-42.55M | $664.00K | 34.85% | 4.97% | -64.09× | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $145.17M | $590.31M | $20.65M | $88.60M | $862.00K | 24.59% | 3.50% | 102.78× | Reported |
| 2011-12-31 | $130.64M | $594.21M | $18.12M | $107.58M | $741.00K | 21.99% | 3.05% | 145.18× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $534.21M | (m) | $121.12M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $65.81M | $307.66M | $5.67M | $18.03M | $1.03M | 21.39% | 1.84% | 17.52× | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $95.23M | $459.01M | $5.63M | $60.08M | $6.66M | 20.75% | 1.23% | 9.02× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.